ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-20.00 (-0.73%)
At close: Sep 11, 2026

KOSDAQ:034940 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2,812-6,806-9,605-10,514560.69-8,044
Depreciation & Amortization
2,3032,4322,3892,3872,3882,893
Loss (Gain) From Sale of Assets
-2,598-1,544-293.83-85.73--8.72
Asset Writedown & Restructuring Costs
1,1291,129246.281,989107.11,938
Loss (Gain) From Sale of Investments
-518.19-450.842.95-171.99-235.85-1,605
Loss (Gain) on Equity Investments
-21.7-7.09-14.78-19.874.83-17.96
Provision & Write-off of Bad Debts
228.47-90.71504.79202.2-230.01269.87
Other Operating Activities
2,9723,9332,6664,3841,8643,899
Change in Accounts Receivable
-1,236450.31,5432,287-2,644400.47
Change in Inventory
2,638700.84596.73-2,212-549.252,292
Change in Accounts Payable
-323.11-1,373-646.98507.621,30481.5
Change in Other Net Operating Assets
-3,561-2,553-1,856-228.1-4,012-3,580
Operating Cash Flow
-1,798-4,180-4,468-1,475-1,443-1,480
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,061-1,986-551.31-831.13-2,782-3,544
Sale of Property, Plant & Equipment
5,3552,612481.47128.61-14.55
Sale (Purchase) of Intangibles
84.36-36.41-229.11-111.52-140.19-319.99
Investment in Securities
444.513,151-1,1591,9441,4791,566
Other Investing Activities
78.87189.62-343.71-398.94-110.22417.53
Investing Cash Flow
4,9023,931-1,802731.38-1,553-1,866

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-30,1669,63015,3497,6589,344
Long-Term Debt Repaid
--28,910-3,406-17,012-5,863-4,621
Net Debt Issued (Repaid)
-1,3121,2566,224-1,6621,7954,723
Other Financing Activities
-736-734-32-27.2211.51101.29
Financing Cash Flow
-2,048521.636,192-1,6901,8074,825

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
73.35-45.09127.94-44.95-33.84106.45
Net Cash Flow
1,129227.5950.04-2,478-1,2231,585

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,859-6,165-5,019-2,306-4,225-5,024
Free Cash Flow Growth
------
Free Cash Flow Margin
-4.67%-10.39%-8.01%-3.66%-6.13%-8.73%
Free Cash Flow Per Share
-461.63-995.08-810.04-372.24-681.86-810.86
Levered Free Cash Flow
-2,983-5,338-894.16-850.27-3,337-3,096
Unlevered Free Cash Flow
-2,187-4,594-197.11-238.19-2,914-2,861

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,2021,0711,026913.95564.55287.07
Cash Income Tax Paid
1.54-3.2714.42-10.98-45.22-
Change in Working Capital
-2,482-2,775-363.43354.91-5,902-805.67